Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May;105(2):319-330.
doi: 10.1177/13872877251327762. Epub 2025 Mar 24.

Improving executive functioning and reducing the risk of Alzheimer's disease with music therapy: A narrative review of potential neural mechanisms

Affiliations
Review

Improving executive functioning and reducing the risk of Alzheimer's disease with music therapy: A narrative review of potential neural mechanisms

Benjamin Slade et al. J Alzheimers Dis. 2025 May.

Abstract

The incidence of Alzheimer's disease (AD) and the concurrent cost of healthcare will increase as the population continues to age. Pharmaceutical interventions effectively manage symptoms of AD but carry side effects and ineffectively address underlying causes and disease prevention. Non-pharmaceutical interventions for AD, such as music training and therapy do not carry these side effects and can improve symptoms, and should therefore be explored as stand-alone or co-therapy for AD. In addition, music encapsulates modifiable lifestyle factors, such as cognitive stimulation, that have been shown to delay progression of and prevent AD. However, the neural mechanisms underpinning how music improves AD symptoms are not fully understood and whether music can target compensatory processes, activate neural networks, or even slow or prevent AD needs further research. Research suggests neural mechanism may involve stimulating brain areas to promote neurogenesis, dopaminergic rewards systems, and the default mode network (DMN). Alternatively, this review proposes that music improve symptoms of AD via the fronto-parietal control network (FPCN), the salience network (SN) and DMN, and neural compensation. This review will then present evidence for how music could activate the FPCN, SN, and DMN to improve their efficiency, organization, and cognitive functions they govern, protecting the brain from damage, slowing progression, and possibly preventing AD. Establishing how music improves symptoms of AD can lead to tailored music therapy protocols that target functional neural networks responsible for impaired executive functions common in AD.

Keywords: Alzheimer's disease; executive functioning; health intervention; music training and therapy; neural networks.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Typical activity of the increased FPCN and SN and decreased DMN during completion of executive functioning tasks. Fronto-Parietal Control Network (Green): DLPFC: dorsal lateral prefrontal cortex; MPC: medial prefrontal cortex; DMPFC: dorsal medial prefrontal cortex; Salience Network (Red): AC: anterior cingulate cortex; AI: anterior insula; VS: ventral striatum; AMYG: amygdala; MTL: medial temporal lobe; HYP: hypothalamus; LC: locus coeruleus; Default Mode Network (Purple): PCC: posterior cingulate cortex; TPJ: temporal parietal junction; IPL: inferior parietal lobule; P: precuneus. (B) Activity of the FPCN and SN and DMN during completion of executive functioning tasks in AD. The SN and FPCN do not increase activation, and DMN does not disengage, leading to impaired processing and performance of executive functioning tasks. (C) Proposed neural mechanisms of how music might improve executive functioning in AD. Increased SN activity occurs via the pre-supplementary motor area (SPMA), which may support FPCN function while DMN decreases, overall improving executive functioning.

References

    1. Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing commission. Lancet 2024; 404: 572–628. - PubMed
    1. Li X, Feng X, Sun X, et al. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019. Front Aging Neurosci 2022; 14: 937486. - PMC - PubMed
    1. Nichols E, Steinmetz JD, Vollset SE, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health 2022; 7: e105–e125. - PMC - PubMed
    1. Power R, Prado-Cabrero A, Mulcahy R, et al. The role of nutrition for the aging population: implications for cognition and Alzheimer's disease. Annu Rev Food Sci Technol 2019; 10: 619–639. - PubMed
    1. Niu H, Álvarez-Álvarez I, Guillén-Grima F, et al. Prevalence and incidence of Alzheimer's disease in Europe: a meta-analysis. Neurología 2017; 32: 523–532. - PubMed

MeSH terms

LinkOut - more resources